Amlodipine And Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 68462-566

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 68462-566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine (Amlodipine)

Chemical structure of Amlodipine and Olmesartan Medoxomil, showing molecular connections and groups typical of the active ingredients in this combination drug.*

FDA Label Image

Figure1 (Figure1)

A line graph showing the proportion of patients with systolic blood pressure (SBP) below 140 mmHg plotted against baseline SBP in mmHg. Four treatment groups are compared: placebo, amlodipine 10 mg, olmesartan medoxomil 40 mg, and amlodipine and olmesartan medoxomil combination tablets 10/40 mg, each represented by different symbols and lines.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the percentage of patients with diastolic blood pressure (DBP) below 90 mmHg across different baseline DBP values ranging from 95 to 110 mmHg. The graph compares four groups: Placebo, Olmesartan Medoxomil 40 mg (OM 40 mg), Amlodipine 10 mg (AML 10 mg), and a combination of Amlodipine and Olmesartan Medoxomil 10/40 mg tablets, showing the greatest effect for the combination therapy.*

FDA Label Image

Figure3 (Figure3)

A line graph showing the relationship between baseline systolic blood pressure (SBP) in mmHg on the x-axis and the proportion of patients achieving SBP less than 130 mmHg on the y-axis (%). The graph compares four groups: Placebo, AML 10 mg (Amlodipine 10 mg), OM 40 mg (Olmesartan Medoxomil 40 mg), and a combination of amlodipine and olmesartan medoxomil tablets 10/40 mg, with distinct markers representing each group.*

FDA Label Image

Figure4 (Figure4)

A line graph showing the percentage of patients with diastolic blood pressure below 80 mmHg plotted against baseline diastolic blood pressure (DBP) ranging from 95 to 110 mmHg. The graph compares results for four groups: placebo, AML 10 mg, OM 40 mg, and a combined Amlodipine and Olmesartan Medoxomil 10/40 mg tablet group.*

FDA Label Image

Lbl10mg 20mg30s

Label for Amlodipine and Olmesartan Medoxomil Tablets, USP 10 mg/20 mg by Glenmark Pharmaceuticals Inc. The label states the quantity as 30 tablets and includes storage instructions, dosage information, and the manufacturer address in New Jersey, USA and India. A barcode and contact information are also visible.*

FDA Label Image

Lbl10mg 40mg30s

Packaging label for Amlodipine and Olmesartan Medoxomil Tablets, USP 10 mg / 40 mg, film-coated oral tablets. The label shows the Glenmark Pharmaceuticals Inc. logo and indicates the quantity as 30 tablets. It includes storage information, dispensing instructions, manufacturer details, and a barcode.*

FDA Label Image

Lbl5mg 20mg30s

Packaging label for Amlodipine and Olmesartan Medoxomil Tablets, USP, showing the 5 mg/20 mg strength. The label states each film-coated tablet contains 6.9 mg amlodipine besylate (equivalent to 5 mg amlodipine) and 20 mg olmesartan medoxomil. The container holds 30 tablets. The manufacturer is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Lbl5mg 40mg30s

Label for Amlodipine and Olmesartan Medoxomil Tablets USP, 5 mg/40 mg strength, film-coated tablets. The label shows the NDC 68462-568-30, package size of 30 tablets, and the manufacturer as Glenmark Pharmaceuticals Inc., USA. Storage instructions and contact information are also visible.*

FDA Label Image

Olmesartanmedoxomil (Olmesartanmedoxomil)

Chemical structure of Amlodipine, shown with detailed molecular bonds and groups as labeled in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.